VIMOVO

Country: ইস্রায়েল

ভাষা: ইংরেজি

সূত্র: Ministry of Health

সক্রিয় উপাদান:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

থেকে পাওয়া:

ASTRA ZENECA ISRAEL LTD

এটিসি কোড:

G02CC02

ফার্মাসিউটিকাল ফর্ম:

TABLETS MODIFIED RELEASE

প্রশাসন রুট:

PER OS

Manufactured by:

ASTRA ZENECA AB., SWEDEN

Therapeutic group:

NAPROXEN

থেরাপিউটিক ইঙ্গিত:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

অনুমোদন তারিখ:

2011-12-01